Introduction: Fabry disease (FD) is a rare metabolic disorder that leads to severe morbidity and premature mortality as a result of cardiac, renal or cerebrovascular complications. Enzyme replacement therapy (ERT) has been shown to provide clinically important benefits, and treatment is likely to alter the natural history of FD.

1. Global Journal of Medical
and Clinical Case Reports
Peertechz Journals

2. Case Report
Angiokeratoma in Fabry Disease Diagnostic
but not Treatment Effectiveness Marker
 Jelena Roganovic, Ingeborg Barisic, Nives Jonjic, Ksenija Fumic and Ana Dordevic
 *Corresponding author: Jelena Roganovic, MD, PhD, Prof., Division of Hematology and
Oncology, Department of Pediatrics, University Children’s Hospital Rijeka, Istarska 43, HR –
51000 Rijeka, Croatia, Tel: ++38551659103; Fax: ++38551623126
 Dates: Received: Received: 28 Septmebr, 2014; Accepted: 13 October, 2014; Published: 15
October, 2014
 Citation: Roganovic J, Barisic I, Jonjic N, Fumic K, Dordevic A (2015) Angiokeratoma in
Fabry Disease: Diagnostic but not Treatment Effectiveness Marker. Global J Med Clin Case
Reports 2(1): 012-013.

3. Abstract
Introduction: Fabry disease (FD) is a rare metabolic disorder
that leads to severe morbidity and premature mortality as a
result of cardiac, renal or cerebrovascular complications.
Enzyme replacement therapy (ERT) has been shown to
provide clinically important benefits, and treatment is likely
to alter the natural history of FD.

4. Thank you
For more information Read Online Article…
http://www.peertechz.com/Clinical-Case-Reports/GJMCCR-2-112.php
http://www.peertechz.com/Clinical-Case-Reports/GJMCCR-1-112.pdf
For
Full
Article
PDF